Yong Ben
Förmögenhet: 86 138 $ per 2026-05-31
Förmögenhet: 86 138 $ per 2026-05-31
Yong Ben is currently an Independent Director at Corbus Pharmaceuticals Holdings, Inc. since 2023.
Dr. Ben is an Independent Non-Executive Director at Geneplus Technology (Shaoxing) Co., Ltd. starting in 2025.
Dr. Ben holds the position of Chief Medical & Development Officer at Bridgebio Oncology Therapeutics, Inc. beginning in 2024 and continuing into 2025.
Dr. Ben is a Venture Partner at Eight Roads Capital Advisors (CHINA) since 2022.
Formerly, Dr. Ben was Chief Medical Officer at BioAtla, Inc. from 2017 to 2019.
Dr. Ben was Chief Medical Officer-Immuno & Oncology Department at BeOne Medicines Ltd. from 2019 to 2022.
Dr. Ben earned an MBA from the University of California San Diego and a doctorate from Norman Bethune Medical University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-19 | 7 583 ( 0,04 % ) | 59 982 $ | 2026-05-31 | |
0 % | 2026-04-20 | 2 916 ( 0 % ) | 26 157 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Direktör/Styrelseledamot | 2023-03-01 |
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Privat kapitalinvesterare | 2022-08-01 |
| Företag | Position | Slut |
|---|---|---|
| BEIGENE LTD | Teknisk/Vetenskaplig/F&U Direktör | - |
| BIOATLA, INC. | Företagsledare/Principal | 2019-02-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norman Bethune Medical University
Norman Bethune Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAtla, Inc.
BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Välj din utgåva
All finansiell information anpassad till den nationella nivån